In support of our observation, the PTGS2 gene promoter has NF-κB and AP-1 binding sites, and activated p65 and c-Jun could induce PTGS2 expression in several cell types, including human cervical cancer cells and human rheumatoid arthritis synovial fibroblasts [39,40]. This evidence concerns the gene FOS and cervical cancer.